Scholar Rock Holding Corp financial data

Symbol
SRRK on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
301 Binney Street, 3 Rd Floor, Cambridge, MA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 12, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 622 % -36%
Debt-to-equity 58.6 % +44%
Return On Equity -146 % -96.8%
Return On Assets -91.8 % -74.6%
Operating Margin -232 % +63.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 93.6M shares +29.8%
Common Stock, Shares, Outstanding 80.1M shares +42.3%
Entity Public Float 158M USD +44.6%
Common Stock, Value, Issued 80K USD +42.9%
Weighted Average Number of Shares Outstanding, Basic 97.1M shares +20.4%
Weighted Average Number of Shares Outstanding, Diluted 97.1M shares +20.4%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 47.3M USD +214%
Research and Development Expense 169M USD +45.1%
General and Administrative Expense 61.6M USD +30.6%
Operating Income (Loss) -231M USD -41%
Nonoperating Income (Expense) 4.76M USD -0.21%
Net Income (Loss) Attributable to Parent -226M USD -42.2%
Earnings Per Share, Basic -2.35 USD/shares -21.8%
Earnings Per Share, Diluted -2.35 USD/shares -21.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 76.4M USD +13%
Marketable Securities, Current 62.7M USD -58.5%
Assets, Current 153M USD -33.1%
Property, Plant and Equipment, Net 3.16M USD -40.3%
Operating Lease, Right-of-Use Asset 16.8M USD +29.5%
Other Assets, Noncurrent 3.81M USD +186%
Assets 179M USD -28.5%
Accounts Payable, Current 4.07M USD +107%
Employee-related Liabilities, Current 9.97M USD +19%
Accrued Liabilities, Current 29.3M USD +68.2%
Liabilities, Current 39.4M USD +47.3%
Operating Lease, Liability, Noncurrent 10.5M USD +65.2%
Liabilities 99.9M USD +20.4%
Accumulated Other Comprehensive Income (Loss), Net of Tax 128K USD
Retained Earnings (Accumulated Deficit) -856M USD -35.9%
Stockholders' Equity Attributable to Parent 79.2M USD -52.8%
Liabilities and Equity 179M USD -28.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -49.8M USD -15.6%
Net Cash Provided by (Used in) Financing Activities 6.53M USD +506%
Net Cash Provided by (Used in) Investing Activities 33.4M USD -62.9%
Common Stock, Shares Authorized 300M shares +100%
Common Stock, Shares, Issued 80.1M shares +42.3%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -9.88M USD -121%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 78.8M USD +12.2%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.66M USD +11.1%
Deferred Tax Assets, Valuation Allowance 217M USD +29.4%
Deferred Tax Assets, Gross 220M USD +27.2%
Operating Lease, Liability 11.8M USD -40%
Payments to Acquire Property, Plant, and Equipment 23K USD -23.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -226M USD -42.9%
Lessee, Operating Lease, Liability, to be Paid 12.5M USD -41.9%
Property, Plant and Equipment, Gross 15.9M USD -9.59%
Operating Lease, Liability, Current 6.04M USD -16.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two 4.5M USD -44.1%
Lessee, Operating Lease, Liability, to be Paid, Year One 8.05M USD -11.1%
Operating Lease, Weighted Average Discount Rate, Percent 0.13 pure +78.9%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 749K USD -61.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 4.5M USD -44.1%
Deferred Tax Assets, Operating Loss Carryforwards 110M USD +17.8%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 0 USD
Operating Lease, Payments 1.98M USD -15.4%
Additional Paid in Capital 935M USD +17.2%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 3.76M USD -35.9%
Share-based Payment Arrangement, Expense 34.1M USD +29.3%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%